vaccines

Responding to the announcement today that the OECD Inclusive Framework on Base Erosion and Profit Shifting has agreed to push ahead with the two-pronged global tax reform deal and set a global minimum corporate tax of 15 percent, Gabriela Bucher, Executive Director of Oxfam International, said:  “This is not an ‘historic’ deal ―it is history repeating itself. Those who shamelessly rigged the global tax system to their benefit over a century ago have again ring-fenced the game for themselves."

Responding to the announcement that COVAX has received more funding and is planning to accelerate its vaccine rollout, Oxfam International’s Head of Inequality Policy, Max Lawson, said: “More funding for COVAX and a quicker rollout of vaccines is a small piece of good news for developing countries struggling to get the doses they need, but at best fewer than a quarter of people in these countries will have been vaccinated by the end of the year."

Max Lawson, Head of Inequality Policy at Oxfam, said: "This G7 summit will live on in infamy. Faced with the biggest health emergency in a century and a climate catastrophe that is destroying our planet, they have completely failed to meet the challenges of our times. Never in the history of the G7 has there been a bigger gap between their actions and the needs of the world."

Responding to early reports of G7 leaders agreeing a 'Carbis Bay Declaration' to end future pandemics faster, Oxfam's Health Policy Manager Anna Marriott said: "It's welcome that G7 leaders are planning measures to end future pandemics faster, but the lack of urgent action to end the current crisis is unforgiveable."

In response to the announcement today from French President, Emmanuel Macron, that France will support a temporary waiver on intellectual property for COVID-19 vaccines, tests and treatments, Oxfam’s Health Policy Manager, Anna Marriott, said: “It is fantastic news that President Macron has joined US President Biden on the right side of history by supporting the calls from India and South Africa, as well as millions of people around the world."

More than a million people have died from COVID since G7 leaders last met back in February, when they made vague pledges to increase the global vaccine supply, but crucially failed to collectively back the waiver of intellectual property rules and investment in manufacturing vaccines in developing countries that would really make the difference.

Anna Marriott, Oxfam Health Policy Manager and Policy co-lead for the People’s Vaccine Alliance said: "The 2021 Global Health Summit ended today in danger of being judged an historical failure of global solidarity to tackle a Covid-19 pandemic that is still, around the world, in its first expanding phase and yet to peak."

Oxfam India welcomes the US decision to back the waiver of intellectual property protections for COVID-19 vaccines.

The United States government last night moved to support a waiver of intellectual property protections of the Covid-19 vaccine. The People’s Vaccine Alliance has been campaigning to suspend Covid-19 intellectual property protections and has this reaction: This is the decision the world needed: by backing a waiver of intellectual property protections for Covid-19 vaccines the Biden Administration can increase the global supply of vaccines and deal a deathblow to the Covid-19 pandemic.

Ahead of shareholder meetings for the giant pharmaceutical corporations, the People’s Vaccine Alliance calculates that Pfizer, Johnson & Johnson and AstraZeneca have paid out $26 billion in dividends and stock buybacks to their shareholders in the past 12 months.